Anti-CAR plus anti-αvβ3 monoclonal antibodies diminished virus infectability by 32%, but treatment with both anti-CAR and anti-αvβ5 antibodies hindered virus infection by less than 20%. The gene discussed is CXADR; the disease is viral infectious disease.